The Global Active Pharmaceutical Ingredients (API) Market: A Frost & Sullivan Briefing on Changin... ( LONDON May 4 /- The Healthcare Group ...)

The Global Active Pharmaceutical Ingredients (API) Market: A Frost & Sullivan Briefing on Changing Dynamics

Date:5/4/2009

LONDON, May 4 /PRNewswire/ -- The Healthcare Group at Frost & Sullivan is pleased to announce its 2009 Quarterly Analyst Briefing Presentation on the Global Active Pharmaceutical Ingredients (API) Market to be held on Wednesday, 6th May 2009, at 3 p.m. GMT.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO)

The API market, traditionally dominated by small molecule drugs, is currently witnessing a rapid shift towards biopharmaceuticals. At the same time the manufacturing volume outsourced to contract manufacturing firms is on the rise. As plain vanilla generics continue to get highly competitive, API manufacturers are searching for newer avenues such as the production of high potency API's to differentiate themselves from competition.

Highlights of this briefing include an analysis of the global API market, challenges facing the global API industry, as well as market drivers and restraints, an estimate on the market size, and a look out on emerging trends. The importance of the Asia-Pacific region as an API manufacturing hub will also be covered in this presentation.

This briefing will benefit API manufacturers, contract manufacturing companies, biotechnology as well as pharmaceutical companies, and the financial community wishing to understand the future potential of the API market.

"It is a difficult time for API manufacturers as they continue to battle challenges such as growing competition from low-cost countries and overcapacity. Market participants will increasingly have to rely on strategies such as capability differentiation and consolidation to stay ahead of competition," observes Pharmaceutical & Biotechnology Programme Leader Sumanth Kambhammettu from Frost & Sullivan.

Frost & Sullivan will hold this conference call at 3 p.m. GMT on Wedne
'/>"/>

7

GOOD

Page: 1 2 3
Related biology technology :

1. Resonant Medical Expands Sales Organization with Appointment of Vice President of Global Sales and Marketing
2. Matt Bars, a Global Expert in Smoking Cessation, Joins Next Safety as Chairman
3. Akaza Research to Present OpenClinica at ACRP Global Conference & Exhibition
4. Bayer CropScience Donates $1.1 Million to United Fresh Research & Education Foundation to Create the Center for Global Produce Sustainability
5. Setting the Benchmark for Winery Tasting Room Research: An Emerging Region Gets a Global Perspective
6. TechConnect Summit Brings the Global Technology Community to Houston, May 4-6, 2009
7. DuPont Leader: Agriculture is Up to Global Productivity Challenge
8. ACM Global Central Lab Announces Partnership with Chindexs United Family Hospitals in China
9. Global Aviation Summit Explores Low-Carbon Flight
10. Global Med Technologies(R) Licenses 90th Site in the Southeastern U.S.
11. NovaBay and Galderma Enter Into Global Agreement to Develop and Commercialize NovaBays Novel Aganocide Drugs for Major Dermatological Conditions

Post Your Comments:

The Global Active Pharmaceutical Ingredients (API) Market: A Frost & Sullivan Briefing on Changin...( LONDON May 4 /- The Healthcare Group ...)